Pluri Inc. Increase (Decrease) in Deferred Revenue
Pluri Inc. (PLUR) reported Increase (Decrease) in Deferred Revenue of -$2.85 million for the 12-month period ending 2016-06-30, per its 10-K filed 2018-09-12.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2018-09-12
- Pluri Inc. increase (decrease) in deferred revenue for the quarter ending 2016-06-30 was $0.00.
- Pluri Inc. increase (decrease) in deferred revenue for the quarter ending 2016-03-31 was $0.00.
- Pluri Inc. increase (decrease) in deferred revenue for the quarter ending 2015-12-31 was -$2.75M.
- Pluri Inc. increase (decrease) in deferred revenue for the quarter ending 2015-09-30 was -$95.00K.
- Pluri Inc. increase (decrease) in deferred revenue for fiscal 2016 was -$2.85M.
- Pluri Inc. increase (decrease) in deferred revenue for fiscal 2015 was -$379.00K.
- Pluri Inc. increase (decrease) in deferred revenue for fiscal 2014 was -$379.00K.
- Pluri Inc. increase (decrease) in deferred revenue for fiscal 2013 was -$679.00K, a 115.85% decline from fiscal 2012.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 6 month as first filed | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 12 month |
|---|---|---|---|---|---|
| 2016-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-09-12 | $0.00 derived: sum of 2 quarters · filed 2018-09-12 | -$2.75M derived: sum of 3 quarters · filed 2018-09-12 | -$2.85M 10-K · filed 2018-09-12 | |
| 2016-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-08 | -$2.75M derived: sum of 2 quarters · filed 2017-05-08 | -$2.85M 10-Q · filed 2017-05-08 | -$2.94M derived: sum of 4 quarters · filed 2017-09-07 | |
| 2015-12-31 | -$2.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-08 | -$2.85M 10-Q · filed 2017-02-08 | -$2.94M derived: sum of 3 quarters · filed 2017-09-07 | -$3.04M derived: sum of 4 quarters · filed 2017-09-07 | |
| 2015-09-30 | -$95.00K 10-Q · filed 2016-11-07 | -$189.00K derived: sum of 2 quarters · filed 2017-09-07 | -$284.00K derived: sum of 3 quarters · filed 2017-09-07 | -$379.00K derived: sum of 4 quarters · filed 2017-09-07 | |
| 2015-06-30 | -$94.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-07 | -$189.00K derived: sum of 2 quarters · filed 2017-09-07 | -$284.00K derived: sum of 3 quarters · filed 2017-09-07 | -$379.00K 10-K · filed 2017-09-07 | |
| 2015-03-31 | -$95.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-09 | -$190.00K derived: sum of 2 quarters · filed 2016-05-09 | -$285.00K 10-Q · filed 2016-05-09 | -$379.00K derived: sum of 4 quarters · filed 2016-09-07 | |
| 2014-12-31 | -$95.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-08 | -$190.00K 10-Q · filed 2016-02-08 | -$284.00K derived: sum of 3 quarters · filed 2016-09-07 | -$379.00K derived: sum of 4 quarters · filed 2016-09-07 | |
| 2014-09-30 | -$95.00K 10-Q · filed 2015-11-05 | -$189.00K derived: sum of 2 quarters · filed 2016-09-07 | -$284.00K derived: sum of 3 quarters · filed 2016-09-07 | $0.00 derived: sum of 4 quarters · filed 2016-09-07 | |
| 2014-06-30 | -$94.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-07 | -$189.00K derived: sum of 2 quarters · filed 2016-09-07 | $95.00K derived: sum of 3 quarters · filed 2016-09-07 | -$379.00K 10-K · filed 2016-09-07 | |
| 2014-03-31 | -$95.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-06 | $189.00K derived: sum of 2 quarters · filed 2015-05-06 | -$285.00K 10-Q · filed 2015-05-06 | -$380.00K derived: sum of 4 quarters · filed 2015-09-09 | |
| 2013-12-31 | $284.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-05 | -$190.00K 10-Q · filed 2015-02-05 | -$285.00K derived: sum of 3 quarters · filed 2015-09-09 | -$480.00K derived: sum of 4 quarters · filed 2015-09-09 | |
| 2013-09-30 | -$474.00K 10-Q · filed 2014-11-06 | -$569.00K derived: sum of 2 quarters · filed 2015-09-09 | -$764.00K derived: sum of 3 quarters · filed 2015-09-09 | -$958.00K derived: sum of 4 quarters · filed 2015-09-09 | |
| 2013-06-30 | -$95.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-09 | -$290.00K derived: sum of 2 quarters · filed 2015-09-09 | -$484.00K derived: sum of 3 quarters · filed 2015-09-09 | -$679.00K 10-K · filed 2015-09-09 | |
| 2013-03-31 | -$195.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-08 | -$389.00K derived: sum of 2 quarters · filed 2014-05-08 | -$584.00K 10-Q · filed 2014-05-08 | -$685.00K derived: sum of 4 quarters · filed 2014-09-11 | |
| 2012-12-31 | -$194.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-02-05 | -$389.00K 10-Q · filed 2014-02-05 | -$389.00 10-Q · filed 2013-01-31 | -$490.00K derived: sum of 3 quarters · filed 2014-09-11 | $3.89M derived: sum of 4 quarters · filed 2014-09-11 |
| 2012-09-30 | -$195.00K 10-Q · filed 2013-11-05 | -$296.00K derived: sum of 2 quarters · filed 2014-09-11 | $4.08M derived: sum of 3 quarters · filed 2014-09-11 | -$757.00K derived: sum of 4 quarters · filed 2014-09-11 | |
| 2012-06-30 | -$101.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-09-11 | $4.28M derived: sum of 2 quarters · filed 2014-09-11 | -$562.00K derived: sum of 3 quarters · filed 2014-09-11 | $4.28M 10-K · filed 2014-09-11 | |
| 2012-03-31 | $4.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-05-08 | -$461.00K derived: sum of 2 quarters · filed 2013-05-08 | $4.38M 10-Q · filed 2013-05-08 | ||
| 2011-12-31 | -$4.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-01-31 | $4.62K 10-Q · filed 2013-01-31 | $4.62M 10-Q · filed 2012-02-09 | ||
| 2011-09-30 | $4.85M 10-Q · filed 2012-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |